Isoform selective PI3 kinase inhibitors for cancer, thrombosis and inflammatory disease

  • Thompson, Phillip (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1531/12/16

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): AUD462,809.20